Thomas Bersot

Internal Medicine physician in San Francisco, California — also lists obesity medicine in the CMS registry.

Practice Details

Address
1001 Potrero Avenue
San Francisco, CA 94110
Geocoded location: 37.7561, -122.4066
Taxonomy
Internal Medicine
Credential
MD
NPPES Enumeration
Listed with NPPES since 2007
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
July 2007

Specialty taxonomies on file (2)

  • Internal Medicine
    Primary
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Thomas Bersot is an Internal Medicine physician in San Francisco whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 1965 Internal Medicine practices in San Francisco carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Thomas Bersot's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 415-206-4615.

GLP-1 access in San Francisco, California

Adult obesity rate
28.1%
#44 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$219/mo
Typical California telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
California Medicaid, obesity indication

About 28.1% of California adults have obesity (BMI 30+), ranking the state #44 of 50 (CDC BRFSS). Our directory currently lists 144 GLP-1-relevant clinics in San Francisco. If a cash-pay route makes more sense, compounded semaglutide through California telehealth averages about $219/mo — well below brand-name Wegovy or Zepbound.

Explore more California options on the best California GLP-1 providers page, browse every San Francisco listing in the San Francisco clinic directory.

Related Practices in San Francisco

Other San Francisco listings in the same directory tier:

Robert Rushakoff
Internal Medicine
Vinh Ngo
Family Medicine
Robert Farese
Internal Medicine

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to California addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured California telehealth partners:

Featured Partners · San Francisco

Featured GLP-1 providers serving San Francisco

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  2. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  3. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  4. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
  5. 7.9
    Trimi Health

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. 8.1
    bmiMD

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
See all 171 GLP-1 providers serving San Francisco ↓

See more San Francisco options on the San Francisco clinic directory, our San Francisco GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by San Francisco obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Thomas Bersot's specialty taxonomy but not the specific medications it prescribes or its current service menu. Thomas Bersot is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 415-206-4615 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Thomas Bersot's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Thomas Bersot is located at 1001 Potrero Avenue, San Francisco, CA 94110. The phone number listed in the registry is 415-206-4615. Its full record is public in the CMS National Provider registry under NPI 1205037629.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Thomas Bersot is currently accepting new patients. Call the practice at 415-206-4615 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.